XSVT issued50,000,000 shares of its unregistered common stock to the Solei Liquidating Trust, which as a result is now the majority common shareholder of XSVT, holding 50,000,000 common shares out of a total of 72\,301,025 total common shares issued and outstanding. As previously reported, Charles O. Scott, the Trustee of the Solei Liquidating Trust, acquired voting control of XSVT by the private acquisition of Series A, Series B and Series C Preferred stock of XSVT, and is also current Chairman and CEO of XSVT. It is the intent of the Trust to distribute all of the shares of XSVT received in the acquisition exchange to the former Solei shareholders in proportion to their holdings in Solei, and the remaining liabilities of Solei held by the Trust will be assumed by Virtual Health Holdings. That distribution will be undertaken as soon as the shares of XSVT held by the Trust are registered in an S-1 or other appropriate registration statement by XSVT. Charles Scott, Chairman and CEO of XSVT and also Trustee of the Seller, Solei Liquidating Trust,stated “We are pleased to apprise our shareholders and all stakeholders of XSOVT and of the CareClix Companies,of the completed acquisition of Virtual Health Holdings Inc. which included CareClix Services Inc, CareClix Network, CareClix RPM, CareClix SAAS, and MyCareClix, a direct-to-consumer company.This transaction represents significant progress toward our continuing goal of building a profitable, US-based international virtual medicine conglomerate to be listed on NASDAQ or NYSE as soon as possible. Collectively the CareClix Group owns the highly rated CareClix Anywhere® software platform, its own medical network, and thepatient coordination and customer service center.Team CareClix, our small group of dedicated and hardworking employees and contractors, efficiently run a stable, virtual medical services company that operates throughout the United States and in 37 countries worldwide, including providing care for the international employees of several Fortune 500 companies. In addition, our current level of activity and existing pipeline of signed and pending contracts is expected to generate sufficient revenue to achieveat least operational breakevenby the end of this year.The blueprint and foundation for growth are set. We are delivering and are confident in our ability to continue to deliver Medical Services, Remote Patient Monitoring, SAAS, and Direct to Consumer Virtual Care verticals, worldwide, as CareClix has been doing for nearly 17 years in the telemedicine space. In addition, Virtual Medicine and Healthcare Space is target rich with potential opportunities to grow revenue through further strategic acquisitions and joint ventures, which we will be in a position to pursue with this acquisition. We are also confident in our ability to procure adequate capital to be primarily invested in IT development, additional management talent, sales and marketing and strategic acquisitions.Clearly, XSOVT is now well positioned to play a pivotal role in the future of medicine
News 
Market Data 
Discover 
